While aiming to assess prostate cancer specific mortality, Sandblom and colleagues indicate a “prostate cancer specific mortality” in the screening group of 35% and in the control group of 45%, which actually is the case fatality rate.1 The true prostate cancer specific mortality was 2% (30/1494) in the screening group and 1.7% (130/7532) in …